Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins

Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins

US Patent 9446048 · Granted Sep 20, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and 2025
c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and 2025
Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)2025
Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)2025
Addition salt of S1P1 receptor agonist and crystal form thereof, and pharmaceuti2025
Selective D3 dopamine receptor agonists and methods of their use2024
Method for inhibiting dengue virus infection2024
Method for inhibiting Zika virus infection2024
Antibody for binding to interleukin 4 receptor2024
Method for inhibiting Zika virus infection2023
Copolyester and use thereof2023
Method for inhibiting dengue virus infection2023